Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment.

Exposure to nanoparticles has presented potential risks to human cardiorespiratory systems. Pulmonary retention and extrapulmonary redistribution of inhaled nanoparticles have been considered to be important contributing factors of cardiorespiratory diseases. In the present work, 22-nm (59)Fe(2)O(3) nanoparticles (radioactive isotope (59)Fe-labeled ferric oxide nanoparticles) were intratracheally instilled into the male Sprague-Dawley rats at a dose of 4 mg/rat. Extrapulmonary distribution of (59)Fe(2)O(3) in organs and its metabolism in lung, blood, urine, and feces were measured for 50 days of exposure. Phagocytosis and clearance of agglomerated nano-Fe(2)O(3) by monocytes/macrophages were observed by histopathology and inductively coupled plasma-mass spectrometry examination. Our results showed intratracheal-instilled nano-(59)Fe(2)O(3) could pass through the alveolar-capillary barrier into systemic circulation within 10 min that consisted with one-compartment kinetic model. The nano-(59)Fe(2)O(3) in the lung was distributed to organs rich in mononuclear phagocytes, including liver, spleen, kidney and testicle. The plasma elimination half-life of nano-(59)Fe(2)O(3) was 22.8 days and the lung clearance rate was 3.06 microg/day, indicating the systemic accumulation and lung retention had occurred. The deposited nano-Fe(2)O(3) in interstitial lung was probably contributed by the particles escaping from alveolar macrophages phagocytosis and macrophages clearance function overloading. Our results suggest that the effect of Fe(2)O(3) nanoparticles exposure, even at low concentration, should be assessed because of the potential lung and systemic cumulative toxicity of the nanoparticles.

[1]  Vicki Stone,et al.  Reduced alveolar macrophage migration induced by acute ambient particle (PM10) exposure , 2008, Cell Biology and Toxicology.

[2]  Meng Wang,et al.  Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. , 2008, Toxicology.

[3]  Manuela Semmler-Behnke,et al.  The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. , 2008, American journal of respiratory cell and molecular biology.

[4]  A. Wexler,et al.  Particle deposition in the pulmonary region of the human lung: Multiple breath aerosol transport and deposition , 2007 .

[5]  Z. Chai,et al.  Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. , 2007, Toxicology letters.

[6]  Hui‐jeong Gwon,et al.  Synthesis of 99mTc‐labeled organo‐germanium nanoparticles and their in vivo study as a spleen imaging agent , 2006 .

[7]  Jianmin Chen,et al.  Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. , 2006, Toxicology.

[8]  Wolfgang Kreyling,et al.  Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.

[9]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[10]  Clement Kleinstreuer,et al.  Comparison of micro- and nano-size particle depositions in a human upper airway model , 2005 .

[11]  E. Hood.  Nanotechnology: Looking As We Leap , 2004, Environmental health perspectives.

[12]  B. Nemery,et al.  Pulmonary toxicity of polyvinyl chloride particles after a single intratracheal instillation in rats. Time course and comparison with silica. , 2004, Toxicology and applied pharmacology.

[13]  W. Stopford,et al.  Bioaccessibility testing of cobalt compounds. , 2003, Journal of environmental monitoring : JEM.

[14]  Robert Gelein,et al.  EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.

[15]  W. Kreyling,et al.  TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW , 2002, Journal of toxicology and environmental health. Part A.

[16]  J. Heyder,et al.  Ultrafine particles cause cytoskeletal dysfunctions in macrophages. , 2002, Toxicology and applied pharmacology.

[17]  L. Mortelmans,et al.  Passage of Inhaled Particles Into the Blood Circulation in Humans , 2002, Circulation.

[18]  M F Hoylaerts,et al.  Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. , 2001, American journal of respiratory and critical care medicine.

[19]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[20]  U. Heinzmann,et al.  Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.

[21]  Ross Upshur,et al.  Acting on an environmental health disaster: the case of the Aral Sea. , 2001, Environmental health perspectives.

[22]  J. Sarnat,et al.  Fine particulate air pollution and mortality in 20 U.S. cities. , 2001, The New England journal of medicine.

[23]  Eger,et al.  Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. , 2000, The New England journal of medicine.

[24]  S Perz,et al.  Increases in heart rate during an air pollution episode. , 1999, American journal of epidemiology.

[25]  L. Horwitz,et al.  Iron-mediated cardiovascular injury , 1999, Vascular medicine.

[26]  W. Kuschner,et al.  Human pulmonary responses to experimental inhalation of high concentration fine and ultrafine magnesium oxide particles. , 1997, Environmental health perspectives.

[27]  J. Gamble,et al.  Health and respirable particulate (PM10) air pollution: a causal or statistical association? , 1996, Environmental health perspectives.

[28]  E G Luebeck,et al.  Particulate air pollution and mortality. , 1996, Epidemiology.

[29]  C. McLaren,et al.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. , 1994, The New England journal of medicine.

[30]  G. Oberdörster,et al.  Pulmonary retention of ultrafine and fine particles in rats. , 1992, American journal of respiratory cell and molecular biology.

[31]  P. Hewitt.  Accumulation of metals in the tissues of occupationally exposed workers , 1988, Environmental geochemistry and health.

[32]  B. Gersh,et al.  Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. , 1987, Journal of the American College of Cardiology.

[33]  J. Peto,et al.  International conference on health hazards and biological effects of welding fumes and gases , 1986 .

[34]  Scott E McNeil,et al.  Nanotechnology safety concerns revisited. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  M. Khazaei,et al.  The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction. , 2007, Pharmacology & therapeutics.

[36]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  P. Hoet,et al.  Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.

[38]  K. Pinkerton,et al.  Pulmonary responses of acute exposure to ultrafine iron particles in healthy adult rats , 2003, Environmental toxicology.

[39]  M. Bando,et al.  Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries , 2002, Cell and Tissue Research.

[40]  G Scheuch,et al.  An approach to deposition and clearance measurements in human airways. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[41]  Marianne Geiser,et al.  Particle Retention in Airways by Surfactant , 1990 .

[42]  Günter Oberdörster,et al.  Lung Clearance of Inhaled Insoluble and Soluble Particles , 1988 .